expected to reschedule cannabis from a Schedule I drug to a Schedule II drug. This move would allow for greater research and potentially open the door for federal legalization in the future. With this change on the horizon, cannabis stocks are poised for a major rebound in 2025. Companies like Canopy Growth (NASDAQ: CGC) and Tilray (NASDAQ: TLRY) could see significant upside as the regulatory environment becomes more favorable.
In conclusion, 2025 is shaping up to be a year of significant change and potential volatility for the stock market. While there are risks on the horizon, there are also opportunities for savvy investors to capitalize on emerging trends and undervalued sectors. By staying informed and keeping a close eye on market developments, investors can position themselves for success in the year ahead.